Last updated on June 2018

Observational Registry of H.P. Acthar Gel for Multiple Sclerosis Relapse

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: relapsing-remitting multiple sclerosis
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Male or Female 18 years of age.
  2. Patient has a clinically definite relapsing form of Multiple Sclerosis according to McDonald Criteria (2010 revision).
  3. Patient with an acute MS exacerbation as determined by their treating clinician.
  4. Patient planning to initiate Acthar Gel for the treatment of an acute MS exacerbation.
  5. Patient capable of providing informed consent.

Exclusion Criteria:

  1. Patients with a diagnosis of Progressive MS.
  2. Patients that require concomitant corticosteroid therapy.
  3. Patients receiving experimental drug therapy.
  4. Patients with a history of scleroderma, systemic fungal infections, ocular herpes simplex within prior 5 years.
  5. Patient has any solid tumor malignancy currently diagnosed or undergoing therapy, or has received therapy for any solid tumor malignancy in the 5 years prior to the Enrollment Visit, with the exception of treated and cured basal cell carcinoma, treated and cured squamous cell carcinoma of the skin, and treated and cured carcinoma in situ of the cervix.
  6. Patients who had recent surgery or have a history of or the presence of a peptic ulcer within 6 months prior to study entry, congestive heart failure, or sensitivity to proteins of porcine origin.
  7. If female, pregnant or breast-feeding; or, if of childbearing age, an unwillingness to use appropriate birth control.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.